NCT05175339View on ClinicalTrials.gov

Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)

CompletedOBSERVATIONAL

Enrollment

26

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions

COVID-19

Trial Locations (2)

21287

Johns Hopkins Hospital, Baltimore

77030

University of Texas Health Science Center, Houston

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT05175339 - Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19) | Biotech Hunter | Biotech Hunter